These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 11005701

  • 1. Is generic prescribing acceptable in epilepsy?
    Besag FM.
    Drug Saf; 2000 Sep; 23(3):173-82. PubMed ID: 11005701
    [Abstract] [Full Text] [Related]

  • 2. [Generic drugs in the treatment of epilepsy].
    González de Dios J, Ochoa-Sangrador C, Sempere AP.
    Rev Neurol; 2000 Sep; 41(11):676-83. PubMed ID: 16317637
    [Abstract] [Full Text] [Related]

  • 3. Is bioavailability altered in generic versus brand anticonvulsants?
    Jankovic SM, Ignjatovic Ristic D.
    Expert Opin Drug Metab Toxicol; 2015 Mar; 11(3):329-32. PubMed ID: 25440299
    [Abstract] [Full Text] [Related]

  • 4. Generic lamotrigine versus brand-name Lamictal bioequivalence in patients with epilepsy: A field test of the FDA bioequivalence standard.
    Ting TY, Jiang W, Lionberger R, Wong J, Jones JW, Kane MA, Krumholz A, Temple R, Polli JE.
    Epilepsia; 2015 Sep; 56(9):1415-24. PubMed ID: 26201987
    [Abstract] [Full Text] [Related]

  • 5. The bioequivalence and therapeutic efficacy of generic versus brand-name psychoactive drugs.
    Borgheini G.
    Clin Ther; 2003 Jun; 25(6):1578-92. PubMed ID: 12860486
    [Abstract] [Full Text] [Related]

  • 6. Understanding therapeutic equivalence in epilepsy.
    Sankar R, Glauser TA.
    CNS Spectr; 2010 Feb; 15(2):112-23. PubMed ID: 20414156
    [Abstract] [Full Text] [Related]

  • 7. Generic antiepileptic drugs-Safe or harmful in patients with epilepsy?
    Holtkamp M, Theodore WH.
    Epilepsia; 2018 Jul; 59(7):1273-1281. PubMed ID: 29894004
    [Abstract] [Full Text] [Related]

  • 8. [The clinical and economic impact of generic drugs in the treatment of epilepsy].
    Argumosa A, Herranz JL.
    Rev Neurol; 2018 Jul; 41(1):45-9. PubMed ID: 15999330
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Assessing bioequivalence of generic antiepilepsy drugs.
    Krauss GL, Caffo B, Chang YT, Hendrix CW, Chuang K.
    Ann Neurol; 2011 Aug; 70(2):221-8. PubMed ID: 21717495
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Recommendations of the Italian League against Epilepsy working group on generic products of antiepileptic drugs.
    Perucca E, Albani F, Capovilla G, Bernardina BD, Michelucci R, Zaccara G.
    Epilepsia; 2006 Aug; 47 Suppl 5():16-20. PubMed ID: 17239100
    [Abstract] [Full Text] [Related]

  • 18. Clinical outcomes associated with brand-to-generic phenytoin interchange.
    Kinikar SA, Delate T, Menaker-Wiener CM, Bentley WH.
    Ann Pharmacother; 2012 May; 46(5):650-8. PubMed ID: 22550275
    [Abstract] [Full Text] [Related]

  • 19. Generic products of antiepileptic drugs (AEDs): is it an issue?
    Bialer M.
    Epilepsia; 2007 Oct; 48(10):1825-32. PubMed ID: 17850324
    [Abstract] [Full Text] [Related]

  • 20. Debate: Substitution of generic drugs in epilepsy: is there cause for concern?
    Gidal BE, Tomson T.
    Epilepsia; 2008 Dec; 49 Suppl 9():56-62. PubMed ID: 19087118
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.